RAD NEWS! 7.04 Rite Aid Corp (RAD)

New Post Public Reply Private Reply Replies (0) Message Board

Apr 13, 2014 at 7:09 PM

Rite Aid Corp (RAD) 7.04 $RAD

Cue the iPhone 6 Near-Field Communication Rumors
Chris Neiger, The Motley Fool - Motley Fool - Sun Apr 13, 12:00PM CDT
Ah, yes, near-field communication (NFC): The wireless connection that was supposed to usher in mobile payments everywhere. Every time a new iPhone is on the horizon rumors of how Apple will most definitely, or most certainly not, adopt the...

5 of Last Week's Biggest Winners
Rick Munarriz, The Motley Fool - Motley Fool - Sun Apr 13, 7:00AM CDT
It was a rocky week on Wall Street, with Nasdaq stocks inching lower and the Dow inching higher, but there were plenty of stocks really making some serious moves. Let's take a closer look at five of this past week's biggest scorchers. ...

Rite Aid's Healthy Earnings, Best Buy's Bad Ones, and Why Tech Stocks Got Short-Circuited All Last W
Jack Kramer and Nick Martell, The Motley Fool - Motley Fool - Sat Apr 12, 6:00PM CDT
As if the last few days before your taxes are due couldn't be more frustrating, the S&P 500 suffered its worst week since January. Despite the start of corporate earnings season, a bunch of IPOs, and pure excitement over the upcoming NHL...

Is Rite Aid a Likely Acquisition Target?
Brian Nichols, The Motley Fool - Motley Fool - Sat Apr 12, 8:05AM CDT
Rite Aid has been at the center of acquisition rumors for years, even before its epic return to profitability. As a business on the rebound with new-found year-over-year revenue growth, Walgreen or CVS might find it attractive. However, if...

Jim Cramer's Top Stock Picks: BAC MSFT RAD
at The Street - Sat Apr 12, 5:00AM CDT
Rite Aid is one of Cramer's favorites for under $10 while Bank of America may reach a bottom by the time it reports earnings.

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Apr 11, 7:09PM CDT
This was a week to forget, Cramer says. But it's still earnings season and here's what he'll be watching.

Most active New York Stock Exchange-traded stocks
AP - Fri Apr 11, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

This Week's 5 Smartest Stock Moves
Rick Munarriz, The Motley Fool - Motley Fool - Fri Apr 11, 4:15PM CDT
If you're feeling good about the market, you're not alone. Take my hand as we go over some of this week's more uplifting headlines. 1. Jeff Bezos is a superhero Amazon.com is getting into the digital comic-books market. The leading online...

3 Stocks Driving The Services Sector Higher
at The Street - Fri Apr 11, 12:02PM CDT
TheStreet highlights 3 stocks pushing the services sector higher today.

Rite Aid Is More Than Just a Turnaround Story Now
Philip Saglimbeni, The Motley Fool - Motley Fool - Fri Apr 11, 12:00PM CDT
After significant doubt on my part, I finally have to admit that the turnaround happening at Rite Aid appears to be real. In fact, the turnaround may be much more than real; it may even be worth investing in. Rite Aid recently announced its...

Rite Aid Has Returned 12.1% Since SmarTrend Recommendation (RAD)
Comtex SmarTrend(R) - Fri Apr 11, 9:43AM CDT
SmarTrend identified an Uptrend for Rite Aid (NYSE:RAD) on February 18th, 2014 at $6.16. In approximately 2 months, Rite Aid has returned 12.11% as of today's recent price of $6.90.

Retail Winners and Losers: Rite Aid, Bed Bath & Beyond, and Family Dollar
Andrés Cardenal, The Motley Fool - Motley Fool - Fri Apr 11, 9:31AM CDT
Shares of Rite Aid , Bed Bath & Beyond , and Family Dollar were making big moves after reporting earnings on Wednesday and Thursday. Let's take a look at these...

Company News for April 11, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 9:06AM CDT
Companies in the News are: FDO,RAD,CBSH,IGTE

Rite Aid (RAD) Jumps: Stock Up 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:39AM CDT
Rite Aid Corporation was a big mover last session, as its shares rose over 8% on the day.

Will This Price Target Increase Help Rite Aid (RAD) Today?
at The Street - Fri Apr 11, 8:26AM CDT
Rite Aid (RAD) has had its price target increased to $7.50, Jefferies said Friday. The firm justified the revision by noting the drugstore chain reported a stronger-than-expected fourth quarter and that it is starting to invest in growth. Jefferies...

Facebook and Netflix Lead Nasdaq Down as Jobless Claims and Rite Aid Improve
Jack Kramer and Nick Martell, The Motley Fool - Motley Fool - Fri Apr 11, 8:17AM CDT
The Dow plummeted 267 points Thursday, while the tech-heavy Nasdaq suffered its worst decline in 2.5 years. 1. Nasdaq Composite stock index falls over 3% The Nasdaq Composite is an index that tracks stocks listed on the Nasdaq stock...

Rite Aid Reaches 52-Week High on Q4 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:00AM CDT
Rite Aid posted better-than-expected fourth-quarter fiscal 2014 results.

Acquisitions, Recognitions, New Stores, and Positive Sales Results - Analyst Notes on Walgreen, Best Buy, McKesson, Target, and Rite Aid
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Walgreen Company (NYSE: WAG), Best Buy Co., Inc. (NYSE: BBY), McKesson Corporation (NYSE: MCK), Target Corporation (NYSE: TGT), and Rite Aid Corporation (NYSE: RAD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

'Fast Money' Recap: The Gains Are Gone
at The Street - Fri Apr 11, 4:00AM CDT
The trading panel discussed what caused Thursday's selloff and what to do next.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...